Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status

Walter M. Stadler, Seth P. Lerner, Susan Groshen, John P. Stein, Shan Rong Shi, Derek Raghavan, David Esrig, Gary Steinberg, David Wood, Laurence Klotz, Craig Hall, Donald G. Skinner, Richard J. Cote

Research output: Contribution to journalArticlepeer-review

177 Scopus citations

Fingerprint

Dive into the research topics of 'Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status'. Together they form a unique fingerprint.

Medicine & Life Sciences